98 related articles for article (PubMed ID: 11374708)
1. Motivations and concerns of patients with access to genetic testing for hereditary pancreatitis.
Applebaum-Shapiro SE; Peters JA; O'Connell JA; Aston CE; Whitcomb DC
Am J Gastroenterol; 2001 May; 96(5):1610-7. PubMed ID: 11374708
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
3. Motivations and psychosocial impact of genetic testing for HNPCC.
Esplen MJ; Madlensky L; Butler K; McKinnon W; Bapat B; Wong J; Aronson M; Gallinger S
Am J Med Genet; 2001 Sep; 103(1):9-15. PubMed ID: 11562928
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of hereditary pancreatitis in a large family, based on high-risk haplotype. The Midwest Multicenter Pancreatic Study Group (MMPSG).
Sossenheimer MJ; Aston CE; Preston RA; Gates LK; Ulrich CD; Martin SP; Zhang Y; Gorry MC; Ehrlich GD; Whitcomb DC
Am J Gastroenterol; 1997 Jul; 92(7):1113-6. PubMed ID: 9219780
[TBL] [Abstract][Full Text] [Related]
5. Hereditary melanoma and predictive genetic testing: why not?
Riedijk SR; de Snoo FA; van Dijk S; Bergman W; van Haeringen A; Silberg S; van Elderen TM; Tibben A
Psychooncology; 2005 Sep; 14(9):738-45. PubMed ID: 15744786
[TBL] [Abstract][Full Text] [Related]
6. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants.
Teich N; Bauer N; Mössner J; Keim V
Am J Gastroenterol; 2002 Feb; 97(2):341-6. PubMed ID: 11866271
[TBL] [Abstract][Full Text] [Related]
7. Searching for hereditary hemochromatosis.
Laudicina RJ
Clin Lab Sci; 2006; 19(3):174-83. PubMed ID: 16910235
[TBL] [Abstract][Full Text] [Related]
8. Disparities in BRCA testing: when insurance coverage is not a barrier.
Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
[TBL] [Abstract][Full Text] [Related]
9. Screening for human cationic trypsinogen (PRSS1) and trypsinogen inhibitor gene (SPINK1) mutations in a Finnish family with hereditary pancreatitis.
Räty S; Piironen A; Babu M; Pelli H; Sand J; Uotila S; Nordback I; Herzig KH
Scand J Gastroenterol; 2007 Aug; 42(8):1000-5. PubMed ID: 17613931
[TBL] [Abstract][Full Text] [Related]
10. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.
Bonadona V; Saltel P; Desseigne F; Mignotte H; Saurin JC; Wang Q; Sinilnikova O; Giraud S; Freyer G; Plauchu H; Puisieux A; Lasset C
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):97-104. PubMed ID: 11815406
[TBL] [Abstract][Full Text] [Related]
11. Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.
Manne SL; Chung DC; Weinberg DS; Vig HS; Catts Z; Cabral MK; Shannon K; Meropol NJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2110-7. PubMed ID: 17932359
[TBL] [Abstract][Full Text] [Related]
12. Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women.
Lewis MJ; Peterson SK
Community Genet; 2007; 10(2):72-81. PubMed ID: 17380056
[TBL] [Abstract][Full Text] [Related]
13. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
[TBL] [Abstract][Full Text] [Related]
14. Duty to warn at-risk relatives for genetic disease: genetic counselors' clinical experience.
Dugan RB; Wiesner GL; Juengst ET; O'Riordan M; Matthews AL; Robin NH
Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):27-34. PubMed ID: 12704635
[TBL] [Abstract][Full Text] [Related]
15. Family communication regarding inherited high cholesterol: why and how do patients disclose genetic risk?
van den Nieuwenhoff HW; Mesters I; Gielen C; de Vries NK
Soc Sci Med; 2007 Sep; 65(5):1025-37. PubMed ID: 17507128
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of 14 individuals who requested predictive genetic testing for hereditary neuromuscular diseases].
Yoshida K; Tamai M; Kubota T; Kawame H; Amano N; Ikeda S; Fukushima Y
Rinsho Shinkeigaku; 2002 Feb; 42(2):113-7. PubMed ID: 12424959
[TBL] [Abstract][Full Text] [Related]
17. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
[TBL] [Abstract][Full Text] [Related]
18. How families communicate about HNPCC genetic testing: findings from a qualitative study.
Peterson SK; Watts BG; Koehly LM; Vernon SW; Baile WF; Kohlmann WK; Gritz ER
Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):78-86. PubMed ID: 12704641
[TBL] [Abstract][Full Text] [Related]
19. What do patients with hereditary deafness think of genetic studies?
Abe S; Noguchi Y; Kitamura K
Auris Nasus Larynx; 2010 Aug; 37(4):422-6. PubMed ID: 20176453
[TBL] [Abstract][Full Text] [Related]
20. Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population.
Peterson EA; Milliron KJ; Lewis KE; Goold SD; Merajver SD
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):79-87. PubMed ID: 11815404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
